Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients

Journal of Diabetes and its Complications

Volumn 22, Issue 3, 2008, Pages 164-170

  Cardoso, Claudia R L ^a   Salles, Gil F ^a  

^a Department of Internal Medicine

Author keywords

Glycaemia left ventricular mass; Microvascular complications; Risk factors; Type 2 diabetes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SULFONYLUREA DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY;

AGED; BRAZIL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 42149096747     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.02.004     Document Type: Article

References (33)

1. Adler A.I., Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., and Smith D.G. Risk factors for diabetic peripheral sensory neuropathy: Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20 (1997) 1162-1167
2. Adler A.I., Stratton I.M., Neil A.W., Yudkin J.S., Matthews D.R., Cull C.A., Wright A.D., Turner R.C., and Holman R.R. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. British Medical Journal 321 (2000) 412-419
3. Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Daviqnon D.R., and Smith D.G. A prospective study of risk factors for diabetic foot ulcer: The Seattle Diabetic Foot Study. Diabetes Care 22 (1999) 1036-1042
4. Cardoso C., Salles G., Bloch K., Deccache W., and Siqueira-Filho A.G. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. International Journal of Cardiology 79 (2001) 253-262
5. Cardoso C., Salles G., and Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: Results of a long-term follow-up prospective study. Journal of Diabetes and its Complications 17 (2003) 169-178
6. Cardoso C.R.L., and Salles G.F. Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients. Diabetes Research and Clinical Practice 75 (2007) 51-58
7. Concato J., Feinstein A.R., and Holford T.R. The risk of determining risk in multivariate models. Annals of Internal Medicine 118 (1993) 201-210
8. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
9. Forrest K.Y.Z., Maser R.E., Pambianco G., Becker D.J., and Orchard T.J. Hypertension as a risk factor for diabetic neuropathy: A prospective study. Diabetes Care 46 (1997) 665-670
10. Gaede P., Vedel P., Larsen N., Jensen G., Parving H.-H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine 348 (2003) 383-393
11. Gall M.A., Hougaard P., Borch-Johnsen K., and Parving H.-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study. British Medical Journal 314 (1997) 783-788
12. Greenland S., and Finkle W.D. A critical look at methods for handling missing covariates in epidemiologic regression analysis. American Journal of Epidemiology 142 (1995) 1255-1264
13. Kohner E., Aldington S.J., Stratton I.M., Manley S.E., Holman R.R., Matthews D.R., and Tuner R.C. United Kingdom Prospective Diabetes Study: Diabetic retinopathy and associated factors (UKPDS 30). Archives of Ophthalmology 116 (1998) 297-303
14. Levy D., Savage D.D., Garrison J., Anderson K.M., Kannel W.B., and Castelli W.P. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. American Journal of Cardiology 59 (1987) 956-960
15. Mbanya J.C., and Sobngwi E. Diabetes microvascular and macrovascular disease in Africa. Journal of Cardiovascular Risk 10 (2003) 97-102
16. Mogensen C.E. Preventing end-stage renal disease. Diabetic Medicine 15 (1998) S51-S56
17. Nazimek-Siewniak B., Moczulski D., and Grzesczak W. Risk of macrovascular and microvascular complications in type 2 diabetes. Results of a longitudinal study design. Journal of Diabetes and its Complications 16 (2002) 271-276
18. Ravid M., Neumann L., and Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type 2: Effects of ACE inhibitors. Kidney International 47 (1995) 907-910
19. Reiber G.E., Pecoraro R.E., and Koepsell T.D. Risk factors for amputation in patients with diabetes mellitus. Annals of Internal Medicine 117 (1992) 97-105
20. Salles G.F., Bloch K., and Cardoso C. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care 27 (2004) 1299-1305
21. Sanchez-Thorin J.C. The epidemiology of diabetes mellitus and diabetes retinopathy. International Ophthalmology Clinics 38 (1998) 11-18
22. Santos K.G., Tschiedel B., Schneider J.R., Souto K.E.P., and Roisenberg I. Prevalence of retinopathy in Caucasian type 2 diabetic patients from the south of Brazil and relationship with clinical and metabolic factors. Brazilian Journal of Medical and Biological Research 38 (2005) 221-225
23. Scheffel R.S., Bortolanza D., Weber C.S., Costa L.A., Canani L.H., Santos K.G., Crispim D., Roisenberg I., Lisboa H.R.K., Tres G.S., Tschiedel B., and Gross J.L. Prevalence of micro and macroangiopathic chronic complications and their risk factors in the care of outpatients with type 2 diabetes mellitus. Revista da Associação Medica Brasileira 50 (2004) 263-267
24. Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., and Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35 (2000) 580-586
25. Stratton I.M., Adler A.I., Neil A.W., Matthews D.R., Manley S.E., Cull C.A., Hadden D., Turner R.C., and Holman R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). British Medical Journal 321 (2000) 405-412
26. Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A.W., and Holman R.R. Additive effects of glycaemia and blood pressure on risk of complications in type 2 diabetes: A prospective observational study (UKPDS 75). Diabetologia 49 (2006) 1761-1769
27. Tesfaye S., Chaturvedi N., Eaton S.E.M., Ward J.D., Manes C., Ionescu-Tirgoviste C., Witte D.R., and Fuller J.H. Vascular risk factors and diabetic neuropathy. New England Journal of Medicine 352 (2005) 341-350
28. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Medicine 122 (1995) 561-568
29. Tudor S.M., Hamman R.F., Baron A., Johnson D.W., and Shetterly S.M. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes: San Luis Valley Diabetes Study Colorado. Diabetes Care 21 (1998) 53-61
30. Tung T.H., Chen S.J., Liu J.H., Lee F.L., Li A.F., Shyong M.P., and Chou P. A community-based follow-up study on diabetic retinopathy among type 2 diabetic in Kinmen. European Journal of Epidemiology 20 (2005) 317-325
31. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
32. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). British Medical Journal 317 (1998) 703-713
33. Van Leiden H.A., Dekker J.M., Moll A.C., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D.A., and Polak B.C.P. Blood pressure, lipids and obesity are associated with retinopathy: The Hoorn study. Diabetes Care 25 (2002) 1320-1325